Author name: Leonardo Arias

Essig filled the vacancy created when Mojdeh Poul and the Integra board mutually decided to end her time as CEO after less than 18 months.

The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.

The healthcare giant increased its adjusted earnings guidance for 2026 by more than 4% as CVS saw “substantial improvement” in its health benefits segment, CFO Brian Newman said on an earnings call.

Sanofi’s investment will support a Canadian site’s efforts to apply AI to drug production, while Amgen has unveiled the second expansion of its Puerto Rico plant in quick succession.

CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.

Robert F. Kennedy Jr.’s health department has consistently touted radical transparency as being key to its mission. Recent instances—the FDA’s decision not to disclose the recipients of three Commissioner’s National Priority Vouchers and FDA and CDC choices not to publish vaccine-related papers—call this intent into question.

Una tecnología de vanguardia, que podría hacer viables las misiones tripuladas a Marte y facilitar las de naves robóticas por todo el sistema solar, fue puesta a prueba recientemente en el Laboratorio de Propulsión a Chorro (JPL) de la NASA en el sur de California, Estado …

A través de un sorprendente experimento de conducta, unos investigadores han demostrado que las cacatúas, o al menos las de la especie Cacatua galerita, son capaces de aprender unas de otras qué nuevos alimentos son seguros de comer. Al igual que el marketing “boca a boca& …

Se sabe que las grandes fallas geológicas pueden guiar el ascenso del magma. ¿Pero también pueden detenerlo? En un nuevo estudio, se ha comprobado hasta qué punto esta segunda conducta es habitual en dichas fallas.   El estudio es obra de un equipo encabezado por S …

Pfizer-backed cancer company CellCentric will use the cash to support the launch of a pivotal myeloma trial testing its potentially first-in-class oral treatment this year.